Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: WST

West Pharmaceutical Services, Inc.

Healthcare | Medical - Instruments & Supplies
$339.97 -2.76 (-0.81%) as of 2026-09-05 03:19 UTC
Market Cap$23.9B
Volume337.8K
EPS (TTM)$6.79

West Pharmaceutical Services, Inc. (NYSE: WST) is a $23.9B medical - instruments & supplies company trading at $339.97 (−0.8% today) — 50.1× trailing earnings, yielding 0.25%. Figures from SEC EDGAR and market feeds; updated 2026-09-05 03:19 UTC.

52-Week Range
Low $290.41High $385.41

What West Pharmaceutical Services, Inc. does

The company is a global manufacturer of integrated containment and delivery systems for injectable drugs and healthcare products, serving biologic, pharmaceutical, and medical device companies. It operates through two segments: Proprietary Products, which offers elastomer-based packaging, drug delivery devices, and analytical services with facilities across North America, South America, Europe, and Asia; and Contract-Manufactured Products, which designs and manufactures complex devices using advanced molding and assembly technologies with facilities in North America and Europe.

Summarized from West Pharmaceutical Services, Inc.’s SEC filings · Read the filing ↗

Key facts

Quote
Price$339.97
Change (1D)-2.76 (-0.81%)
Market cap$23.9B
Volume337.8K shares
52-week range$290.41 – $385.41
Valuation
P/E (TTM)50.07×
EV/EBITDA30.90×
EPS (TTM)$6.79
Dividend yield0.25%
Price/book7.53×
Return on equity15.54%
Debt/equity0.06
Returns
52-week return+17.1%

Revenue, margins & earnings

FY2021 Net income: $662MFY2021 Taxes & interest: $90MFY2021 Operating expenses: $424MFY2021 Cost of revenue: $1.66B$2.83BFY2021FY2022 Net income: $586MFY2022 Taxes & interest: $148MFY2022 Operating expenses: $402MFY2022 Cost of revenue: $1.75B$2.89BFY2022FY2023 Net income: $593MFY2023 Taxes & interest: $83MFY2023 Operating expenses: $453MFY2023 Cost of revenue: $1.82B$2.95BFY2023FY2024 Net income: $493MFY2024 Taxes & interest: $77MFY2024 Operating expenses: $429MFY2024 Cost of revenue: $1.89B$2.89BFY2024FY2025 Net income: $494MFY2025 Taxes & interest: $91MFY2025 Operating expenses: $519MFY2025 Cost of revenue: $1.97B$3.07BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-12
  • 2026-08-12McMahon Robert W.SVP & Chief Financial OfficerF-345$121.4K
  • 2026-08-12McMahon Robert W.SVP & Chief Financial OfficerM794—
  • 2026-08-12McMahon Robert W.SVP & Chief Financial OfficerM6,354—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does West Pharmaceutical Services, Inc. do?

The company is a global manufacturer of integrated containment and delivery systems for injectable drugs and healthcare products, serving biologic, pharmaceutical, and medical device companies.

What is WST's valuation?

WST trades at $339.97, 50.07× trailing earnings, 30.90× EV/EBITDA, as of 2026-09-05. It carries a 0.25% dividend yield.

When did WST last file with the SEC?

West Pharmaceutical Services, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-07-23. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-05 03:19 UTC. This page is also available as JSON at /api/data?ticker=WST and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for WST and 5,000+ tickers.

Create a free account — keep WST
For your agent
GET /api/data?ticker=WST

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt